SCIENCE 37

Resources

 
SCIENCE 37

Resources

 
All the DCT insights you need, from our world-class experts.
Insight Brief
In this new insight brief, Science 37 CEO David Coman explains how agile and decentralized approaches actually offer sponsors more centralized command and oversight compared to traditional study design.
Centralize Clinical Trials with Decentralized Clinical Trials.
Research has shown that every sponsor is looking for faster trial execution, reduced patient burden, and greater patient engagement/retention. The smartest industry leaders are…
Download the insight brief here
/Resources/centralize-clinical-trials-decentralized-clinical-trials
Report
The DEPICT Act - new US legislation aimed at boosting diversity in clinical trials
The DEPICT Act
Are you prepared for the DEPICT Act? The industry is making significant headway in delivering diversity in clinical trials, and the time to do more is now. 

On February 3, 2022, Rep…
Learn More
/Resources/depict-act
Blog
Learn More
Motivated by the Urgency for a Better Way: Researcher, Joannie Hayes’s Background Fuels Her Work and Reflection on Black History Month
Learn More
/motivated-urgency-better-way-researcher-joannie-hayess-background-fuels-her-work-and-reflection
Blog
As a child Nortorious thought she wanted to be a doctor. While in school, however, she uncovered her true passion—research—studying science to help prevent people from avoiding poor health. Her heart as a researcher fuels her perspective about Black History Month and the importance of studying and honoring those who came before us as we work toward a better future.
The Heart of a Researcher: Science-Centered Nortorious Coleman-Taylor Highlights the Importance of Black History Month
Learn More
/heart-researcher-science-centered-nortorious-coleman-taylor-highlights-importance-black-history
Blog
Ryan Brown shares with us the details of a webinar hosted by Real Chemistry during the recent J.P. Morgan Conference on January 12. It focused on trust as it relates to diversity, equity and inclusion (DE&I) in the world of health, and the ways we can strive to reach the goal of being truly inclusive.
Building Trust – and the Bottom Line – by Future-Proofing Health With Innovation that is Truly Inclusive
Learn More
/building-trust-and-bottom-line-future-proofing-health-innovation-truly-inclusive
Blog
learn more about reshaping trials in 2022, click here to download our latest report
Reshaping Clinical Trials in 2022
Learn More
/reshaping-clinical-trials-2022
Blog
As we kick off Black History Month, we reflect back on the recent Halloran Consulting Group Town Hall webinar and our discussion about achieving Diversity, Equity and Inclusion (DE&I) and breaking the boundaries that exist in our pursuit to procure bias-free clinical trial outcomes.
Achieving Better Clinical Trial Outcomes by Strategically Targeting Neglected Patient Populations
Learn More
/achieving-better-clinical-trial-outcomes-strategically-targeting-neglected-patient-populations
Blog
Scientist Turned Advocate: Ryan Brown Shares Black History Month’s Dual Importance
Scientist Turned Advocate: Ryan Brown Shares Black History Month’s Dual Importance
Every February, Black History Month provides us a unique opportunity: It’s our chance to take pause and honor, recognize and celebrate the many past, present and underappreciated…
Learn More
/scientist-turned-advocate-ryan-brown-shares-black-history-months-dual-importance
Blog
Privacy By Design Protects Clinical Trial Participants
Privacy By Design Protects Clinical Trial Participants
Happy Data Privacy Day!  But, really, isn’t every day privacy day?  As Science 37’s Privacy Officer, I certainly take that approach. Protecting the privacy rights and freedoms of…
Learn More
/privacy-design-protects-clinical-trial-participants
Blog
How Access to the HPV Vaccination is helping to Eliminate Cervical Cancer
How Access to the HPV Vaccination is helping to Eliminate Cervical Cancer
With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that The human papillomavirus, or HPV, the vaccine is cutting cases of cervical cancer by nearly 90%.
Learn More
/how-access-hpv-vaccination-helping-eliminate-cervical-cancer
Blog
S37
Working with Native Americans to Navigate the COVID-19 Crisis
This Native American Heritage Month, we take a look at how the COVID-19 crisis has highlighted long standing inequities, as well as the fight to overcome them.
Learn More
/Resources/Working-with-Native-Americans-to-Navigate
Case Study
The Clinical Trial of the Future Survey Report
The Clinical Trial of the Future Survey Report
New data suggests we are approaching a milestone on the tech-enabled path to a patient-focused future.
Learn More
/Agile-Clinical-Trial-Report
Case Study
Enabling Diversity in Cancer Screening Study
Enabling Diversity in Cancer Screening Study
We take a bespoke approach to all our trials. We understand every therapeutic area is different. We performed a careful review of trial design, inclusion/exclusion criteria, and review…
Download the full case study for more insight
/Resources/enabling-diversity-cancer-screening-study
Case Study
This case study highlights the success we had in providing a flexible approach in a COVID19 study, to a non-for-profit sponsor, to quickly access a more representative patient population.
Ensuring Diversity in a COVID-19 study
We take a bespoke approach to all our trials. We understand every therapeutic area is different. We perform careful review of trial design, inclusion/exclusion criteria, and review of…
Download the full case study for more insight
/Resources/ensuring-diversity-covid-19-study
Report
Decentralized Clinical Trial
The Decentralized Clinical Trial Operating System
A requisite, technology-first platform with limitless configurations to enable clinical research.
Learn More
/DCT-OS-Report
White Paper
Clinical Research in the COVID-19 Era: Methods for Continuity
Clinical Research in the COVID-19 Era: Methods for Continuity
Adjust ongoing trials and have the changes expeditiously reviewed by an accredited IRB.
Learn More
/Covid-19
Factsheet
Empowering Diversity in Clinical Trials
Empowering Diversity in Clinical Trials
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers.  The Diversity in Clinical Trials…
Download our fact sheet for more insight
/Resources/empowering-diversity-clinical-trials
White Paper
Navigating Clinical Trials in the Coronavirus Era
Navigating Clinical Trials in the Coronavirus Era
Explore approaches to mitigate risks to patient safety in ongoing clinical trials.
Learn More
/Covid-19

Providers

Are you a healthcare professional
looking for more details?

Contact us today to learn more